BARCLAYS PLC: PLAB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on PLAB, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 37,682 PLAB shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 37,682 sharesChange vs previous 13F +26,501 shares
<0.01% of the 13F portfolio, value $1,225,795.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 11,181 sharesChange vs previous 13F -74,547 shares
<0.01% of the 13F portfolio, value $451,824.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 85,728 sharesChange vs previous 13F +4,650 shares
<0.01% of the 13F portfolio, value $1,967,457.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 81,078 sharesChange vs previous 13F -34,623 shares
<0.01% of the 13F portfolio, value $1,683,180.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 115,701 sharesChange vs previous 13F +1,568 shares
<0.01% of the 13F portfolio, value $2,725,918.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 114,133 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $2,825,935.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).